When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLU - Bellus Health completes enrollment in mid-stage BLU-5937 trial
BELLUS Health Inc.
BELLUS Health (BLU) has completed patient enrollment for the RELIEF trial, its dose-escalation Phase 2 study of BLU-5937 in patients with refractory chronic cough.
More news on: BELLUS Health, Healthcare stocks news,